Yahoo Canada Web Search

Search results

1. Images

   • 
   • 
   • 
   • 
   • 

   View all

2. novotech-cro.com › news › novotech-health-holdingsNovotech Health Holdings Announces Appointment of Anand ...

   novotech-cro.com › news › novotech-health-holdings

   • Cached

   Dec 8, 2020 · SHANGHAI and SYDNEY, 8 December 2020 – Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia, today announced the appointment of Anand Tharmaratnam as Chairman of the Board commencing 1 April 2021.

3. novotech-cro.com › our-managementOur Management | Novotech CRO

   novotech-cro.com › our-management

   • Cached

   Anand brings over 20 years of experience in global drug development and the CRO industry. He was previously the president of Asia Pacific at IQVIA. Anand is a medical doctor by training and graduated from the University College London, UK and trained in the anaesthesia.

   • 
   • 
   • 
   • 

4. www.marketscreener.com › news › latestNovotech Health Holdings : Announces Appointment of Anand ...

   www.marketscreener.com › news › latest

   • Cached

   Dec 8, 2020 · SHANGHAI and SYDNEY, Dec. 8, 2020 /PRNewswire/ -- Novotech Health Holdings ("Novotech Holdings"), the largest biotech specialist contract research organization (CRO) in Asia, today announced the appointment of Anand Tharmaratnam as Chairman of the Board commencing 1 April 2021.

5. uk.linkedin.com › in › anandtharmaratnamAnand Tharmaratnam - Novotech Health Holdings | LinkedIn

   uk.linkedin.com › in › anandtharmaratnam

   Anand is a seasoned healthcare executive with 26 years of industry experience.<br><br>An… · Experience: Novotech Health Holdings · Education: Royal College of Anaesthetists · Location:...

   • Connections: 500+
   • Followers: 1.1K

   • Education: Royal College of Anaesthetists
   • Works For: Novotech Health Holdings

6. novotech-cro.com › dr-anand-tharmaratnamDr. Anand Tharmaratnam | Novotech CRO

   novotech-cro.com › dr-anand-tharmaratnam

   • Cached

   Dr. Anand Tharmaratnam. Anand brings over 20 years of experience in global drug development and the CRO industry. He was previously the president of Asia Pacific at IQVIA. Anand is a medical doctor by training and graduated from the University College London, UK and trained in the anaesthesia.

7. www.manufacturingchemist.com › news › article_pageNovotech appoints Anand Tharmaratnam as Chairman

   www.manufacturingchemist.com › news › article_page

   • Cached

   Novotech Health Holdings, a major biotech specialist contract research organisation (CRO) in Asia, has appointed Anand Tharmaratnam as Chairman of the Board commencing 1 April 2021. Dr Tharmaratnam brings over 23 years of experience in global drug development and the CRO industry.

8. en.prnasia.com › releases › globalNovotech Health Holdings Announces Appointment of Anand ...

   en.prnasia.com › releases › global

   • Cached

   Dec 8, 2020 · SHANGHAI and SYDNEY, Dec. 8, 2020 /PRNewswire/ -- Novotech Health Holdings Announces Appointment of Anand Tharmaratnam as Chairman